OPTIKIRA, LLC

Follow

Organization

CLEVELAND, OH, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition
- Patent number 11,649,237
- Issue date May 16, 2023
- Optikira LLC
- Richard M. Keenan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Pyrazolopyridine Compounds and Methods of Inhibiting IRE1 Using Same
- Publication number 20230331719
- Publication date Oct 19, 2023
- Optikira, LLC
- Richard Keenan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolopyridine Compounds For IRE1 Inhibition
- Publication number 20220194945
- Publication date Jun 23, 2022
- Optikira, LLC
- Richard Keenan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrazolopyridine Compounds For IRE1 Inhibition
- Publication number 20220153734
- Publication date May 19, 2022
- Optikira, LLC
- Richard Keenan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IRE1 INHIBITION
- Publication number 20200354367
- Publication date Nov 12, 2020
- Optikira LLC
- Richard M. Keenan
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks